Ectopic fat storage in the pancreas, liver, and abdominal fat depots: Impact on β-cell function in individuals with impaired glucose metabolism

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 2, 2011, Pages 459-467

  Van Der Zijl, N J ^a   Goossens, G H ^b   Moors, C C M ^b   Van Raalte, D H ^a   Muskiet, M H A ^a   Pouwels, P J W ^a   Blaak, E E ^b   Diamant, M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE;

ABDOMINAL FAT; ADULT; AGED; ARTICLE; BODY MASS; CELL FUNCTION; CONTROLLED STUDY; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; LIPID STORAGE; LIVER; LIVER FAT CONTENT; MAJOR CLINICAL STUDY; MALE; PANCREAS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PANCREATIC FAT ACCUMULATION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SUBCUTANEOUS FAT;

ABDOMINAL FAT; AGED; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FASTING; FATS; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OVERWEIGHT; PANCREAS; PANCREATIC FUNCTION TESTS; PREDIABETIC STATE; SUBCUTANEOUS FAT;

EID: 79951705814     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1722     Document Type: Article

References (39)

1. Paolisso G, Tataranni PA, Foley JE, Bogardus C, Howard BV, Ravussin E 1995 A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM. Diabetologia 38:1213-1217
2. Lupi R, Dotta F, Marselli L, Del Guerra S, Masini M, Santangelo C, Patané G, Boggi U, Piro S, Anello M, Bergamini E, Mosca F, Di Mario U, Del Prato S, Marchetti P 2002 Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that β-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 51:1437-1442 (Pubitemid 34826609)
3. Poitout V, Robertson RP 2008 Glucolipotoxicity: fuel excess and β-cell dysfunction. Endocr Rev 29:351-366 (Pubitemid 351679704)
4. Unger RH, Zhou YT 2001 Lipotoxicity of β-cells in obesity and in other causes of fatty acid spillover. Diabetes 50(Suppl 1):S118-S121 (Pubitemid 32148232)
5. Robertson RP, Harmon J, Tran PO, Poitout V 2004 β-Cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. Diabetes 53(Suppl 1):S119-S124
6. Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, Lewis GF 1999 Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol 276:E1055-E1066 (Pubitemid 29323421)
7. Paolisso G, Gambardella A, Amato L, Tortoriello R, D'Amore A, Varricchio M, D'Onofrio F 1995 Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 38:1295-1299
8. Leung N, Sakaue T, Carpentier A, Uffelman K, Giacca A, Lewis GF 2004 Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic β-cell function in obese men. Diabetologia 47:204-213 (Pubitemid 38315356)
9. Blaak EE, van Aggel-Leijssen DP, Wagenmakers AJ, Saris WH, van Baak MA 2000 Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. Diabetes 49:2102-2107
10. Goossens GH 2008 The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance. Physiol Behav 94:206-218 (Pubitemid 351615418)
11. Boden G, Chen X, Ruiz J, White JV, Rossetti L 1994 Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446 (Pubitemid 24177157)
12. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI 1996 Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest 97:2859-2865 (Pubitemid 26197099)
13. Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S, Romijn JA, de Roos A, Lamb HJ 2008 Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 52:1793-1799
14. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH 1994 β-Cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-β-cell relationships. Proc Natl Acad Sci USA 91:10878-10882
15. Lingvay I, Esser V, Legendre JL, Price AL, Wertz KM, Adams-Huet B, Zhang S, Unger RH, Szczepaniak LS 2009 Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 94: 4070-4076
16. Tushuizen ME, Bunck MC, Pouwels PJ, Bontemps S, van Waesberghe JH, Schindhelm RK, Mari A, Heine RJ, Diamant M 2007 Pancreatic fat content and β-cell function in men with and without type 2 diabetes. Diabetes Care 30:2916-2921 (Pubitemid 350083144)
17. Saisho Y, Butler AE, Meier JJ, Monchamp T, Allen-Auerbach M, Rizza RA, Butler PC 2007 Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat 20:933-942 (Pubitemid 350074312)
18. Heni M, Machann J, Staiger H, Schwenzer NF, Peter A, Schick F, Claussen CD, Stefan N, Häring HU, Fritsche A 2010 Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study. Diabetes Metab Res Rev 26:200-205
19. DeFronzo RA, Tobin JD, Andres R 1979 Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223 (Pubitemid 9249478)
20. Lee Y, Lingvay I, Szczepaniak LS, Ravazzola M, Orci L, Unger RH 2010 Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int J Obes 34:396-400
21. Provencher SW 1993 Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 30:672-679
22. Elbers JM, Haumann G, Asscheman H, Seidell JC, Gooren LJ 1997 Reproducibility of fat area measurements in young, non-obese subjects by computerized analysis of magnetic resonance images. Int J Obes Relat Metab Disord 21:1121-1129 (Pubitemid 27511486)
23. Bunck MC, Diamant M, Cornér A, Eliasson B, Malloy JL, Shaginian RM, Deng W, Kendall DM, Taskinen MR, Smith U, Yki-Järvinen H, Heine RJ 2009 One-year treatment with exenatide improves β-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial. Diabetes Care 32:762-768
24. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte Jr D 1984 Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 74:1318-1328 (Pubitemid 15206828)
25. Utzschneider KM, Prigeon RL, Carr DB, Hull RL, Tong J, Shofer JB, Retzlaff BM, Knopp RH, Kahn SE 2006 Impact of differences in fasting glucose and glucose tolerance on the hyperbolic relationship between insulin sensitivity and insulin responses. Diabetes Care 29:356-362 (Pubitemid 44106518)
26. Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, Okunade A, Klein S 2009 Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 106:15430-15435
27. Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Balletshofer B, Machicao F, Fritsche A, Häring HU 2008 Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 168:1609-1616
28. Szendroedi J, Roden M 2009 Ectopic lipids and organ function. Curr Opin Lipidol 20:50-56
29. van Herpen NA, Schrauwen-Hinderling VB 2008 Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav 94:231-241 (Pubitemid 351615422)
30. Randle PJ 1998 Regulatory Interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 14:263-283 (Pubitemid 29110250)
31. Tushuizen ME, Bunck MC, Pouwels PJ, Diamant M 2008 Pancreatic fat content and β-cell function in men with and without type 2 diabetes: response to Saisho, Butler, and Butler. Diabetes Care 31:e39
32. Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, Unger RH 1998 Lipoapoptosis in β-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 273:32487-32490 (Pubitemid 28557623)
33. van Raalte DH, van der Zijl NJ, Diamant M 2010 Pancreatic steatosis in humans: cause or marker of lipotoxicity? Curr Opin Clin Nutr Metab Care 13:478-485
34. Kashyap S, Belfort R, Gastaldelli A, Pratipanawatr T, Berria R, Pratipanawatr W, Bajaj M, Mandarino L, DeFronzo R, Cusi K 2003 A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes 52:2461-2474 (Pubitemid 37210533)
35. Carpentier A, Mittelman SD, Lamarche B, Bergman RN, Giacca A, Lewis GF 1999 Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol 276:E1055-E1066 (Pubitemid 29323421)
36. Rahier J, Goebbels RM, Henquin JC 1983 Cellular composition of the human diabetic pancreas. Diabetologia 24:366-371 (Pubitemid 13092224)
37. Jensen MD 2008 Role of body fat distribution and the metabolic complications of obesity. J Clin Endocrinol Metab 93(11 Suppl 1):S57-S63
38. Faerch K, Borch-Johnsen K, Holst JJ, Vaag A 2009 Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? Diabetologia 52:1714-1723
39. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP, et al. 1993 Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 42:1663-1672 (Pubitemid 23318125)